MktsMarkets

Haemonetics Corporation
NYSE: HAEKey statistics
HAE News
Stories mentioning HAE from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 28 | Q4 '25Dec 27 | Q3 '25Sep 27 | Q2 '25Jun 28 | Q1 '25Mar 29 | Q4 '24Dec 28 | Q3 '24Sep 28 | Q2 '24Jun 29 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 346,351 | 338,967 | 327,315 | 321,394 | 330,599 | 348,542 | 345,511 | 336,172 |
| Cost of Goods Sold | 148,139 | 136,581 | 132,571 | 129,150 | 137,549 | 154,995 | 158,074 | 161,248 |
| Gross Profit | 198,212 | 202,386 | 194,744 | 192,244 | 193,050 | 193,547 | 187,437 | 174,924 |
| Operating Expenses | ||||||||
| Research & Development | 14,446 | 14,187 | 14,872 | 16,261 | 18,305 | 15,829 | 14,139 | 14,449 |
| Sales General & Admin | 120,933 | 109,154 | 101,615 | 110,719 | 115,136 | 106,459 | 106,946 | 108,248 |
| Total Operating Expenses | 221,237 | 134,990 | 136,253 | 138,372 | 121,715 | 134,518 | 135,740 | 135,168 |
| Operating Income (Loss) | (23,025) | 67,396 | 58,491 | 53,872 | 71,335 | 59,029 | 51,697 | 39,756 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (5,374) | (7,421) | (7,206) | (8,703) | (598.00) | (9,112) | (6,993) | 6,957 |
| Pretax Income | (28,399) | 59,975 | 51,285 | 45,169 | 70,737 | 49,917 | 44,704 | 46,713 |
| Tax Provision | (8,252) | 15,235 | 12,601 | 11,138 | 12,756 | 12,423 | 10,873 | 8,340 |
| Net Income (Loss) | (20,147) | 44,740 | 38,684 | 34,031 | 57,981 | 37,494 | 33,831 | 38,373 |
| Earnings Per Share (Basic) | (0.43) | 0.96 | 0.81 | 0.71 | 1.15 | 0.75 | 0.66 | 0.75 |
| Earnings Per Share (Diluted) | (0.43) | 0.95 | 0.81 | 0.70 | 1.14 | 0.74 | 0.66 | 0.74 |
| Weighted Average Shares Outstanding (Basic) | 47,179 | 46,792 | 47,590 | 48,111 | 50,330 | 50,286 | 50,898 | 50,943 |
| Weighted Average Shares Outstanding (Diluted) | 47,354 | 46,987 | 47,664 | 48,353 | 50,730 | 50,639 | 51,240 | 51,564 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About HAE
Haemonetics Corporation (NYSE: HAE) is a stock listed on the New York Stock Exchange under the ticker symbol HAE. It last traded at $120.92 (Nov 17, 2026, 4:00 PM ET), down 0.3% on the day. That gives Haemonetics a market capitalisation of $5.5B and a price-to-earnings ratio of 53.0.
Over the past 52 weeks HAE has traded between $51.00 and $132.00.
Revenue for the quarter ended Mar 28, 2026 was $346.4M; a net loss of $20.1M. Revenue was up 4.8% from $330.6M in the quarter ended Mar 29, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 28, 2026 | $346.4M | -$20.1M | -5.8% |
| Dec 27, 2025 | $339.0M | $44.7M | 13.2% |
| Sep 27, 2025 | $327.3M | $38.7M | 11.8% |
| Jun 28, 2025 | $321.4M | $34.0M | 10.6% |
From Haemonetics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…